Your search returned 11 results.

Results
	1.	BiRd (clarithromycin, lenalidomide, dexamethasone): an update on long-term lenalidomide therapy in previously untreated patients with multiple myeloma. [electronic resource] by Rossi, Adriana Mark, Tomer Jayabalan, David Christos, Paul Zafar, Faiza Pekle, Karen Pearse, Roger Chen-Kiang, Selina Coleman, Morton Niesvizky, Ruben Producer: 20130513 In: Blood vol. 121 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Analysis of Common Eligibility Criteria of Randomized Controlled Trials in Newly Diagnosed Multiple Myeloma Patients and Extrapolating Outcomes. [electronic resource] by Shah, Jatin J Abonour, Rafat Gasparetto, Christina Hardin, James W Toomey, Kathleen Narang, Mohit Srinivasan, Shankar Kitali, Amani Zafar, Faiza Flick, E Dawn Rifkin, Robert M Producer: 20180510 In: Clinical lymphoma, myeloma & leukemia vol. 17 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Prophylactic low-dose aspirin is effective antithrombotic therapy for combination treatments of thalidomide or lenalidomide in myeloma. [electronic resource] by Niesvizky, Ruben Martínez-Baños, Déborah Jalbrzikowski, Jessica Christos, Paul Furst, Jessica De Sancho, Maria Mark, Tomer Pearse, Roger Mazumdar, Madhu Zafar, Faiza Pekle, Karen Leonard, John Jayabalan, David Coleman, Morton Producer: 20080304 In: Leukemia & lymphoma vol. 48 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Stem cell mobilization with cyclophosphamide overcomes the suppressive effect of lenalidomide therapy on stem cell collection in multiple myeloma. [electronic resource] by Mark, Tomer Stern, Jessica Furst, Jessica R Jayabalan, David Zafar, Faiza LaRow, April Pearse, Roger N Harpel, John Shore, Tsiporah Schuster, Michael W Leonard, John P Christos, Paul J Coleman, Morton Niesvizky, Ruben Producer: 20080804 In: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation vol. 14 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Thalidomide, clarithromycin, lenalidomide and dexamethasone therapy in newly diagnosed, symptomatic multiple myeloma. [electronic resource] by Mark, Tomer M Bowman, Isaac A Rossi, Adriana C Shah, Manan Rodriguez, Melissa Quinn, Ryann Pearse, Roger N Zafar, Faiza Pekle, Karen Jayabalan, David Ely, Scott Coleman, Morton Chen-Kiang, Selina Niesvizky, Ruben Producer: 20150818 In: Leukemia & lymphoma vol. 55 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Lenalidomide-induced myelosuppression is associated with renal dysfunction: adverse events evaluation of treatment-naïve patients undergoing front-line lenalidomide and dexamethasone therapy. [electronic resource] by Niesvizky, Ruben Naib, Tara Christos, Paul J Jayabalan, David Furst, Jessica R Jalbrzikowski, Jessica Zafar, Faiza Mark, Tomer Lent, Richard Pearse, Roger N Ely, Scott Leonard, John P Mazumdar, Madhu Chen-Kiang, Selina Coleman, Morton Producer: 20071108 In: British journal of haematology vol. 138 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Treatment Outcomes and Health Care Resource Utilization in Patients With Newly Diagnosed Multiple Myeloma Receiving Lenalidomide-only Maintenance, Any Maintenance, or No Maintenance: Results from the Connect MM Registry. [electronic resource] by Rifkin, Robert M Jagannath, Sundar Durie, Brian G M Narang, Mohit Terebelo, Howard R Gasparetto, Cristina J Toomey, Kathleen Hardin, James W Wagner, Lynne Parikh, Kejal Abouzaid, Safiya Srinivasan, Shankar Kitali, Amani Zafar, Faiza Abonour, Rafat Producer: 20190903 In: Clinical therapeutics vol. 40 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Health related quality of life for multiple myeloma patients according to treatment strategy after autologous stem cell transplant: a cross-sectional study using EORTC, EQ-5D and MY-20 scales. [electronic resource] by Tay, Jason Vij, Ravi Norkin, Maxim Buadi, Francis Kindwall-Keller, Tamila L Roberts, Jenna S White, Darrell J Wood, Robert P Blanthorn-Hazell, Sophee E Rossi, Adriana C Dhanasiri, Sujith Zafar, Faiza Newhouse, Kim McCurdy, Arleigh R Producer: 20200713 In: Leukemia & lymphoma vol. 60 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	Pomalidomide plus low-dose dexamethasone in relapsed refractory multiple myeloma after lenalidomide treatment failure. [electronic resource] by Siegel, David S Schiller, Gary J Song, Kevin W Agajanian, Richy Stockerl-Goldstein, Keith Kaya, Hakan Sebag, Michael Samaras, Christy Malek, Ehsan Talamo, Giampaolo Seet, Christopher S Mouro, Jorge Pierceall, William E Zafar, Faiza Chung, Weiyuan Srinivasan, Shankar Agarwal, Amit Bahlis, Nizar J Producer: 20200727 In: British journal of haematology vol. 188 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	10.	Overcoming the response plateau in multiple myeloma: a novel bortezomib-based strategy for secondary induction and high-yield CD34+ stem cell mobilization. [electronic resource] by Niesvizky, Ruben Mark, Tomer M Ward, Maureen Jayabalan, David S Pearse, Roger N Manco, Megan Stern, Jessica Christos, Paul J Mathews, Lena Shore, Tsiporah B Zafar, Faiza Pekle, Karen Xiang, Zhaoying Ely, Scott Skerret, Donna Chen-Kiang, Selina Coleman, Morton Lane, Maureen E Producer: 20130923 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 19 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	11.	BiRD (Biaxin [clarithromycin]/Revlimid [lenalidomide]/dexamethasone) combination therapy results in high complete- and overall-response rates in treatment-naive symptomatic multiple myeloma. [electronic resource] by Niesvizky, Ruben Jayabalan, David S Christos, Paul J Furst, Jessica R Naib, Tara Ely, Scott Jalbrzikowski, Jessica Pearse, Roger N Zafar, Faiza Pekle, Karen Larow, April Lent, Richard Mark, Tomer Cho, Hearn J Shore, Tsiporah Tepler, Jeffrey Harpel, John Schuster, Michael W Mathew, Susan Leonard, John P Mazumdar, Madhu Chen-Kiang, Selina Coleman, Morton Producer: 20080326 In: Blood vol. 111 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)